The experience of risk as 'measured vulnerability': Health screening and lay uses of numerical risk

Sociology of Health and Illness

Volumn 34, Issue 2, 2012, Pages 194-207

  Gillespie, Chris ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

Health risk assessment; Health screening; Hypercholesterolemia; Measured vulnerability; PSA test; Uncertainty

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; HEALTH STATUS; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MASS SCREENING; METHODOLOGY; PROSTATE TUMOR; RISK ASSESSMENT; UNCERTAINTY; UNITED STATES;

HEALTH STATUS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; UNCERTAINTY; UNITED STATES;

EID: 84857503840     PISSN: 01419889     EISSN: 14679566     Source Type: Journal    
DOI: 10.1111/j.1467-9566.2011.01381.x     Document Type: Article

References (57)

1. Ablin, Richard J. (2010) The great prostate mistake, New York Times, 9 March, OpEd.
2. Armstrong, D. (1995) The rise of surveillance medicine, Sociology of Health and Illness, 17, 3, 393-404.
3. Aronowitz, R. (1998) Making Sense of Illness: Science, Society, and Disease. Cambridge: Cambridge University Press.
4. Aronowitz, R. (2009) The convergence experience of risk and disease, The Milbank Quarterly, 87, 2, 417-42.
5. Arnst, C. (1999) The risk of disease will be treated as a disease, Business Week (3644).
6. Brown, J., Chapman, S. and Lupton, D. (1996) Infinitesimal risk as public health crisis: news media coverage of a doctor-patient HIV contact tracing investigation, Social Science and Medicine, 43, 12, 1685-95.
7. Bury, M. (1982) Chronic illness as biograhical disruption, Sociology of Health and Illness, 4, 2, 167-82.
8. Bury, M. (1991) The sociology of chronic illness: a review of research and prospects, Sociology of Health and Illness, 13, 4, 451-68.
9. Catalona, W.J. (1992) Single and serial measurement of serum prostate-specific antigen as a screening test for early prostate cancer, Journal of Urology, 147, 450A.
10. Charmaz, K. (1983) Loss of self: a fundamental form of suffering in the chronically ill, Sociology of Health and Illness, 5, 2, 168-95.
11. Charmaz, K. (1987) Struggling for a self: identity levels of the chronically ill. In Roth, J.A. and Conrad, P. (eds) Research in the Sociology of Health Care. Greenwich, CT: JAI Press.
12. Clark, J.A. and Talcott, J.A. (2006) Confidence and uncertainty long after initial treatment for early prostate cancer: survivors' views of cancer control and the treatment decisions they made, Journal of Clinical Oncology, 24, 27, 4457-63.
13. Clarke, E., Mamo, L., Fishman, J.R., et al. (2003) Biomedicalization: technoscientific transformations of health, illness, and U.S. biomedicine, American Sociological Review, 68, April, 161-94.
14. Conrad, P. (1985) The meaning of medications: another look at compliance, Social Science and Medicine, 20, 1, 29-37.
15. Conrad, P. (2007) The Medicalization of Society. Baltimore, Md.: Johns Hopkins University Press.
16. Crawford, R. (2004) Risk ritual and the management of control and anxiety in medical culture, Health, 8, 4, 505-28.
17. Eastham, J., Riedel, E., Scardino, P.T., et al. (2003) Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuation, JAMA, 289, 20, 2695-700.
18. Evans, R., Edwards, A.G., Elwyn, G., et al. (2007) 'It's a Maybe Test': men's experience of prostate specific antigen testing in primary care, British Journal of General Practice, 57, 303-10.
19. Foucault, M. (1988) Technologies of the self. In Martin, L.H., Gutman, H. and Hutton, P.H. (eds) Technologies of the Self. Amhert: University of Massachusetts Press.
20. Foucault, M. (1991) Governmentality. In Burchell, G., Gardon, C. and Miller, P. (eds) The Foucault Effect: Studies in Governmentality. Chicago: University of Chicago Press.
21. Fowler, F.J. (2006) The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes, Journal of General Internal Medicine, 21, 7, 715-21.
22. Frank, A. (1995) The Wounded Storyteller: Body, Illness, and Ethics. Chicago: University of Chicago Press.
23. Frich, J. (2007) Experiences of guilt and shame in patients with familial hypercholesterolemia: a qualitative interview study, Patient Education and Counseling, 69, 1-3, 108-13.
24. Garrety, K. (1998) Science, policy, and controversy in the cholesterol arena, Symbolic Interaction, 21, 4, 401-24.
25. Greaves, D. (2000) The creation of partial patients, Cambridge Quarterly of Healthcare Ethics, 9, 23-37.
26. Greene, J. (2007) Prescribing by Numbers. Baltimore: Johns Hopkins University Press.
27. Goffman, E. (1963) Stigma: Notes on the Management of a Spoiled Identity. Englewood Cliffs, NJ: Prentice-Hall.
28. Goffman, E. (1967) Interaction Ritual. New York: Pantheon.
29. Kabat, G.C. (2008) Hyping Health Risks: Envoronmental Hazards in Daily Life and the Science of Epidemiology. New York: Columbia University Press.
30. Keeley, B., Wright, L. and Condit, C.M. (2009) Functions of health and fatalism: fatalistic talk as face saving, uncertainty management, stress relief and sense making, Sociology of Health and Illness, 31, 5, 734-47.
31. Lidskog, R. (1996) In science we trust? On the relation between scientific knowledge, risk consciousness and public trust, Acta Sociologica, 39, 1, 31-56.
32. Lupton, D. (1995) The Imperative of Health: Public Health and the Regulated Body. London: Sage.
33. Lupton, D. (1999) Risk. London: Routledge.
34. Meyers, G. (2003) Risk and face: a review of the six studies, Health, Risk and Society, 5, 2, 215-20.
35. Mishel, Merle. H. (1990) Reconceptualization of the uncertainty in illness theory, IMAGE: Journal of Nursing Scholarship, 22, 4, 256-62.
36. National Center for Health Statistics. (2009) Health, 2008, United States with Chartbook. Hyattsville: Md.
37. National Cholesterol Education Panel. (1988) Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults, Archives of Internal Medicine, 148, 36-69.
38. National Cholesterol Education Panel. (2001) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) - Executive Summary, National Heart, Lung, and Blood Institute.
39. Navon, L. and Morag, A. (2004) Liminality as biographical disruption: unclassifiability following hormonal therapy for advanced prostate cancer, Social Science and Medicine, 58, 11, 2337-47.
40. Nelkin, D. (1989) Communicating technological risk: the social construction of risk perception, Annual Review of Public Health, 10, 95-113.
41. Nerlich, B. and Koteyko, N. (2008) Balancing food risks and food benefits: the coverage of probiotics in the UK national press, Sociological Research Online, 13, 3, 21.
42. Nettleton, S., Burrows, R. and Watt, I. (2005) The mundane realities of the everyday lay use of the internet for health, and their consequences for media convergence, Sociology of Health and Illness, 27, 7, 972-92.
43. Paterson, B. (2001) The shifting perspectives model of chronic illness, Journal of Nursing Scholarship, 33, 1, 21-6.
44. Pound, P. (2005) Resisting medicines: a synthesis of qualitative studies of medicine taking, Social Science and Medicine, 61, 1, 133-55.
45. Rosenberg, C. (2009) Managed fear, The Lancet, 373, 802-03.
46. Sachs, L. (1996) Causality, responsibility and blame - core issues in the cultural construction and subtext of prevention, Sociology of Health and Illness, 18, 5, 632-52.
47. Schneider, J.W. and Conrad, P. (1983) Having Epilepsy: the Experience and Control of Illness. Philadelphia, PA: Temple University Press.
48. Scott, S., Prior, L., Wood, F and Gray, J. (2005) Repositioning the patient: the implications of being 'at-risk', Social Science and Medicine, 60, 8, 1869-79.
49. Siegrist, M., Keller, C., Kastenholz, H., et al. (2007) Laypeople's and experts' perception of nanotechnology hazards, Risk Analysis, 27, 1, 59-69.
50. Sulik, G. (2009) Managing biomedical uncertainty: the techonoscientific illness identity, Sociology of Health and Illness, 31, 7, 1059-76.
51. Timmermans, S. and Buchbinder, M. (2010) Patients-in-waiting: living between sickness and health in the genomics era, Journal of Health and Social Behavior, 51, 4, 408-23.
52. Weiss, M. (1997) Signifying the pandemics: metaphors of AIDS, cancer, and heart disease, Medical Anthropology Quarterly, 11, 4, 456-76.
53. Weitz, R. (1989) Uncertainty and the lives of persons with AIDS, Journal of health & social behavior, 30, 3, 270-81.
54. Will, C. (2005) Arguing about the evidence: readers, writers and inscription devices in coronary heart disease assessment, Sociology of Health and Illness, 27, 6, 780-801.
55. Williams, S. (2000) Chronic Illness as biographical disruption or biological disruption as chronic illness? Reflection on a core concept, Sociology of Health and Illness, 22, 5, 40-67.
56. Woodward, K. (1999) Statistical panic, Differences: a Journal of Feminist Cultural Studies, 11, 2, 178-203.
57. Woodward, K. (2003) The Statistical body. In Coupland, J. and Gwyn, R. (eds) Discourse, the Body, and Identity. London: Palgrave Macmillan.